The incidence and mortality rate of Breast Cancer (BC) are global problems for women, with
over 2.1 million new diagnoses each year worldwide. There is no age range, race, or …

Breast cancer (BC) is the second most common cancer among women, comprising 34% of
all cancers, affecting∼ 2.23 million women every year globally. Therefore, early diagnosis of …

Purpose Insufficient sensitivity and specificity prevent the use of most existing biomarkers for
early detection of breast cancer. Recently, it was reported that serum microRNAs (miRNAs) …

Abstract Cancer Antigen 15-3 (CA 15-3) and the extracellular domain of the human
epidermal growth factor receptor 2 (HER2-ECD) are independent breast cancer biomarkers …

Nanosized (30–150 nm) extracellular vesicles 'exosomes' are secreted by cells for
intercellular communication during normal and pathological conditions. Exosomes carry …

Electrochemical immunosensors (EIs) for the determination of disease biomarkers has
attracted a wide interest due to its high sensitivity, low cost, and possible integration in …

Despite the evolution of targeted therapies in oncology, some challenges such as screening
and early diagnosis of cancer-related biomarkers still remain. The analysis of the Human …

Screening and early diagnosis are crucial to increase the success of cancer patients'
treatments and improve the survival rate. To contribute to this success, distinct …

Breast cancer (BrCa) is the most frequent cancer type in women and a leading cause of
cancer related deaths in the world. Despite the decrease in mortality due to better …

Breast cancer is currently the most common form of cancer and the second‐leading cause of
death from cancer in women. Though considerable progress has been made in the …